ReShape Lifesciences Inc. (RSLS) Total Assets by Year
ReShape Lifesciences Inc. closed fiscal year 2025 with $6.5M in total assets, $2.7M in total liabilities and $3.8M in shareholder equity. This represents an increase of 370.3% from the prior fiscal year. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters ReShape Lifesciences Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RSLS Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.5M+370.3% | $1.4M-87.0% | $10.7M-4.3% | $11.1M-78.8% | $52.5M+41.7% | $37.1M+81.7% | $20.4M-32.9% | $30.4M-42.8% | $53.1M-32.6% | $78.8M+454.0% | $14.2M | N/A |
| Total Liabilities | $2.7M-52.6% | $5.8M-65.7% | $16.8M+125.1% | $7.5M-8.7% | $8.2M-63.7% | $22.6M+707.8% | -$3.7M-121.5% | $17.3M-3.9% | $18.0M+24.3% | $14.5M-79.1% | $69.4M | N/A |
| Total Equity | $3.8M+185.7% | -$4.4M+28.9% | -$6.2M-268.6% | $3.7M-91.7% | $44.3M+206.0% | $14.5M-39.9% | $24.1M+83.9% | $13.1M-62.7% | $35.1M-45.4% | $64.3M+216.6% | -$55.1M-38.3% | -$39.9M |
RSLS Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'25 | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'24 | Q2'2410-Q | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.2M+605.8% | $6.5M+370.3% | $7.0M+451.2% | $1.6M+17.9% | $1.4M-82.5% | $1.4M-87.0% | $1.3M-83.7% | $1.4M-88.4% | $8.2M-49.7% | $10.7M-4.3% | $7.8M-70.4% | $11.9M-70.6% |
| Total Liabilities | $2.1M+906.2% | $2.7M-52.6% | $3.1M+1598.3% | $6.6M+23.7% | $213K-94.2% | $5.8M-65.7% | -$209K-104.4% | $5.4M+4.6% | $3.7M-57.0% | $16.8M+125.1% | $4.7M-37.0% | $5.1M-46.6% |
| Total Equity | $8.0M+553.8% | $3.8M+185.7% | $2.5M+70.1% | -$5.0M-25.7% | $1.2M-72.9% | -$4.4M+28.9% | $1.5M-51.8% | -$4.0M-158.9% | $4.5M-41.6% | -$6.2M-268.6% | $3.1M-83.7% | $6.7M-78.1% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More ReShape Lifesciences Inc. financials
Frequently Asked Questions
What was ReShape Lifesciences Inc.'s total assets in fiscal year 2025?
ReShape Lifesciences Inc. closed fiscal year 2025 with $6.5M in total assets, $2.7M in total liabilities and $3.8M in shareholder equity.
How fast is ReShape Lifesciences Inc.'s total assets growing?
ReShape Lifesciences Inc. (RSLS) total assets rose by 370.3% year over year, from $1.4M to $6.5M in fiscal year 2025.
What was ReShape Lifesciences Inc.'s total assets in the most recent quarter?
ReShape Lifesciences Inc. (RSLS) reported $10.2M in total assets in Q1 2026. This represents an increase of 605.8% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what ReShape Lifesciences Inc. (RSLS) reported on that line in every period on record.